Literature DB >> 20576696

Lockhart Clarke's contribution to the description of amyotrophic lateral sclerosis.

Martin R Turner1, Michael Swash, George C Ebers.   

Abstract

The definition of the clinicopathological entity of amyotrophic lateral sclerosis evolved over half a century. Although the definitive term amyotrophic lateral sclerosis that acknowledged both upper and lower motor neuron involvement was attributed to Jean-Martin Charcot in 1874, his initial case was published nearly a decade earlier; and it is accepted that, from at least the 1830s, several others (including Charles Bell, François-Amilcar Aran and Jean Cruveilhier) had already recognized a progressive lower motor neuron-only syndrome within a broader, clinically-defined group of disorders, termed progressive muscular atrophy. Although William Gowers first grouped the three phenotypes of amyotrophic lateral sclerosis, progressive muscular atrophy and progressive bulbar palsy together as part of the same syndrome, the term motor neuron disease, as an over-arching label, was not suggested until nearly a century later by W. Russell Brain. Augustus Jacob Lockhart Clarke (1817-80) is best known for his descriptions of spinal cord anatomy. However, in two detailed case reports from the 1860s, he carried out rigorous post-mortem neuropathological studies of what appear to be classical cases of amyotrophic lateral sclerosis. Furthermore, he recognized the additional involvement of the corticospinal tracts that distinguished this from progressive muscular atrophy. Several aspects of the exquisite clinical histories documented as part of both studies, one by Charles Bland Radcliffe, resonate with contemporary debates concerning the evolution of disease in amyotrophic lateral sclerosis. These 'past masters' still have much to teach us.

Entities:  

Mesh:

Year:  2010        PMID: 20576696      PMCID: PMC3182545          DOI: 10.1093/brain/awq097

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  40 in total

1.  Amyotrophic lateral sclerosis--the Edinburgh disease?

Authors:  J D Mitchell
Journal:  J Hist Neurosci       Date:  1992-01       Impact factor: 0.529

2.  A4V superoxide dismutase mutation in apparently sporadic ALS resembling neuralgic amyotrophy.

Authors:  M D Weiss; J M Ravits; N Schuman; G T Carter
Journal:  Amyotroph Lateral Scler       Date:  2006-03

3.  Neuralgic amyotrophy; the shoulder-girdle syndrome.

Authors:  M J PARSONAGE; J W A TURNER
Journal:  Lancet       Date:  1948-06-26       Impact factor: 79.321

4.  Animal electricity and the birth of electrophysiology: the legacy of Luigi Galvani.

Authors:  M Piccolino
Journal:  Brain Res Bull       Date:  1998-07-15       Impact factor: 4.077

5.  The overlap of amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Catherine Lomen-Hoerth; Thomas Anderson; Bruce Miller
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

6.  Eye movement in amyotrophic lateral sclerosis: a longitudinal study.

Authors:  A Palmowski; W H Jost; J Prudlo; J Osterhage; B Käsmann; K Schimrigk; K W Ruprecht
Journal:  Ger J Ophthalmol       Date:  1995-11

7.  Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase.

Authors:  T Juneja; M A Pericak-Vance; N G Laing; S Dave; T Siddique
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

8.  Pattern of spread and prognosis in lower limb-onset ALS.

Authors:  Martin R Turner; Alice Brockington; Jakub Scaber; Hannah Hollinger; Rachael Marsden; Pamela J Shaw; Kevin Talbot
Journal:  Amyotroph Lateral Scler       Date:  2010-08

Review 9.  Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron?

Authors:  A Eisen; S Kim; B Pant
Journal:  Muscle Nerve       Date:  1992-02       Impact factor: 3.217

Review 10.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec
View more
  6 in total

1.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

2.  Jacob Augustus Lockhart Clarke (1817-1880).

Authors:  Ibrahim Demircubuk; Esra Candar; Gulgun Sengul
Journal:  J Neurol       Date:  2022-09-17       Impact factor: 6.682

Review 3.  The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey.

Authors:  Martin R Turner; Michael Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-02-02       Impact factor: 10.154

Review 4.  Motoneuron firing in amyotrophic lateral sclerosis (ALS).

Authors:  Mamede de Carvalho; Andrew Eisen; Charles Krieger; Michael Swash
Journal:  Front Hum Neurosci       Date:  2014-09-22       Impact factor: 3.169

5.  A(a)LS: Ammonia-induced amyotrophic lateral sclerosis.

Authors:  Bhavin Parekh
Journal:  F1000Res       Date:  2015-05-14

6.  Eye-tracking in amyotrophic lateral sclerosis: A longitudinal study of saccadic and cognitive tasks.

Authors:  Malcolm Proudfoot; Ricarda A L Menke; Rakesh Sharma; Claire M Berna; Stephen L Hicks; Christopher Kennard; Kevin Talbot; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-08-27       Impact factor: 4.092

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.